CLASS II Drug recall · Reported 29 Nov 2017 · FDA Enforcement Report

Pravastatin Sodium USP, tablets, 40 mg recalled by Lupin

Lupin is recalling Pravastatin Sodium USP, tablets, 40 mg, distributed nationwide in the US. The recall was initiated on 17 Nov 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # G702459, Exp 2/20
NDC68180-485, 68180-486, 68180-487, 68180-488
UPC0368180487098
Quantity recalledN/A

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0092-2018
FDA event ID
78566
Recalling firm
Lupin, Vasco Da Gama, N/A
Manufacturer
Lupin Pharmaceuticals, Inc.
Classification
Class II
Status
Terminated
Recall initiated
17 Nov 2017
FDA classified
21 Nov 2017
Reported
29 Nov 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

17 Nov 2017Recall initiated by company
21 Nov 2017Classified by FDA+4 days
29 Nov 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.

Product as listed by the FDA

Pravastatin Sodium USP, tablets, 40 mg, 90-count bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, NDC 68180-487-09

Where it was distributed

Product was distributed throughout the United States, including Puerto Rico.

Nationwide Puerto Rico

Questions about this recall

Is Pravastatin Sodium USP, tablets, 40 mg recalled?

Yes. Lupin recalled Pravastatin Sodium USP, tablets, 40 mg on 17 Nov 2017. The recall is Class II and its status is Terminated. Recall number D-0092-2018.

Why was it recalled?

Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.

Which lots are affected?

Lot # G702459, Exp 2/20

Where was it sold?

Product was distributed throughout the United States, including Puerto Rico.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Lupin

All 4
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIEscitalopram Tablets USP 20 mg recalled by LupinEscitalopramLupinOtherNationwide
DrugCLASS IIIAmlodipine Besylate Tablets USP, 10mg recalled by LupinAmlodipine BesylateLupinManufacturing (CGMP) Deviations
DrugCLASS IIIAmlodipine Besylate Tablets USP, 5mg recalled by LupinAmlodipine BesylateLupinManufacturing (CGMP) Deviations

Other Pravastatin recalls

All 17